Prof. Mohajeri
🔹 Next-generation vaccines
🔹 Protein-Mediated Virulence in Mycobacterium tuberculosis
🔹 CNN-based image recognition of Acid-Fast Bacilli in sputum smears
🔹 Deep learning for automated sputum smear microscopy in tuberculosis diagnosis
🔹 Prediction of multidrug-resistant tuberculosis in tuberculosis patients using perceptron artificial
neural networks model
🔹 Molecular links between tuberculosis and lung cancer
🔹 Type I interferons in tuberculosis pathogenesis and prevention
🔹 The role of TRIM proteins in the pathogenesis of mycobacterium tuberculosis
🔹 Advances and Challenges in Mycobacterial Genetic Engineering
🔹 AI-powered risk prediction of tuberculosis
🔹 Antimicrobial resistance mechanisms in non-tuberculous mycobacteria
🔹 “Pupdates” on proteasomal degradation in bacteria
🔹 Host-directed therapy for tuberculosis
Dr. Abiri
🔹 Oral-Brain axis, Role of oral microbiota in Neurodegenerative disorders
🔹 Oral-Brain axis, Role of oral microbiota in Neuropsychiatric disorders
🔹 Oral-Brain axis, Role of oral microbiota in Cardiovascular disorders
🔹 Skin microbiome
🔹 Clinical applications of bacterial extracellular vesicles
🔹 Diagnosis applications of CRISPR Cas systems
🔹 Different methods of gene cloning
🔹 Bacteria- Cancer Interactions
🔹 Quorum sensing in treatment of Bacterial Infections
Dr. Taki
🔹 AI-Based Prediction of Bacterial Infections and Antimicrobial Resistance
🔹 Machine Learning in Clinical Decision-Making for Bacterial Infections
🔹 Gut Microbiota Dysbiosis and Its Role in Bacterial Infections
🔹 Environmental Reservoirs of Clinically Relevant Bacteria
🔹 Wastewater Surveillance for Antimicrobial Resistance Genes
🔹 Bacterial Infections in Immunocompromised Patients: Emerging Challenges
🔹 Bacterial Biofilms in Chronic and Device-Associated Infections
🔹 Antibiotic Resistance in the Post-COVID Era: Lessons from ICU Settings
🔹 Quorum Sensing Noise: A Novel Strategy for Biofilm Control Without Antibiotics
🔹 Impact of Host Stress Signals on Quorum Sensing-Mediated Biofilm Formation
🔹 Quorum Sensing-Mediated Biofilm Dispersal as a Therapeutic Strategy
🔹 Host Hormones as Modulators of Bacterial Quorum Sensing and Biofilms
Dr. Pajavand
🔹The role of carbon dots in the treatment of bacterial infections
🔹The role of carbon dots in the diagnosis of bacterial infection
🔹The role of metformin on gut microbiota in people with type 2 diabetes
🔹The role of empagliflozin on gut microbiota in people with type 2 diabetes
🔹The roll of -natural medicine for rapid hemostasis and diabetic wound management
🔹The role of bacteria in children's development by affecting GH-IGF-1
Dr. Alvandi
| 🔹 | Metagenomic (Next-Generation Sequencing) in Clinical Bacteriology: Revolutionizing Diagnos or Metabolomics-Based Diagnostics in Clinical Bacteriology
|
| 🔹 | Artificial Intelligence and Machine Learning Applications in Clinical Microbiology Laboratories
|
| 🔹 | In Silico Clinical Trials for Antibacterial Drug Development |
| 🔹 | Microbiome-Based and Commensal-Derived Bacterial Vaccines or Gut Microbes as Therapeutics |
| 🔹 | Rapid Diagnostics vs. Clinical Reality: Barriers to Implementing Molecular Tests in infectious diseases or Molecular Diagnostics in Clinical Bacteriology: Impact on Patient Outcomes and Antibiotic Use
|
| 🔹 | Endolysin against bacteria or Bacteriophage Endolysins as Antibacterial Agents
|
| 🔹 | Natural Sources Derived Antimicrobial Peptides
|
| 🔹 | Antimicrobial inflammasomes
|
| 🔹 | Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy |
| 🔹 | Biochemistry of Bacterial Biofilm
|
| 🔹 | Synthetic Biology in Engineering of Lactic Acid Bacteria
|
| 🔹 | Update on Vaccines against bacterial meningitis
|
| 🔹 | Bacterial Immune Evasion Strategies
|
| 🔹 | Role of Bacteria in Chronic Inflammatory Diseases
|
| 🔹 | Point-of-Care Testing for Bacterial Infections: Impact on Clinical Decision-Making or Rapid Testsin Clinical Bacteriology and its Future Impact
|
| 🔹 | Biofilms in Device-Associated Infections: Clinical Relevance, Diagnosis, and Treatment Approaches |
| 🔹 | Optimizing Blood Culture Practices: Pre-Analytical, Analytical, and Post-Analytical Considerations |
| 🔹 | Advancements in Rapid AST Technologies |
| 🔹 | CRISPR-Based Antimicrobials in Clinical Practice
|
| 🔹 | Quality Management in Clinical Bacteriology Labs
|